|
Albert, P S; McShane, L M; Shih, J H et al. (2001) Latent class modeling approaches for assessing diagnostic error without a gold standard: with applications to p53 immunohistochemical assays in bladder tumors. Biometrics 57:610-9
|
|
LaRue, H; Allard, P; Simoneau, M et al. (2000) P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers. Carcinogenesis 21:101-6
|
|
Pfister, C; Larue, H; Moore, L et al. (2000) Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes. Int J Cancer 89:100-4
|
|
McShane, L M; Aamodt, R; Cordon-Cardo, C et al. (2000) Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network. Clin Cancer Res 6:1854-64
|
|
Simoneau, M; LaRue, H; Aboulkassim, T O et al. (2000) Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest. Oncogene 19:6317-23
|
|
Pfister, C; Lacombe, L; Vezina, M C et al. (1999) Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors. Hum Pathol 30:1350-5
|
|
Simoneau, M; Aboulkassim, T O; LaRue, H et al. (1999) Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31. Oncogene 18:157-63
|
|
Pfister, C; Moore, L; Allard, P et al. (1999) Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence. Clin Cancer Res 5:4079-84
|
|
Orlow, I; LaRue, H; Osman, I et al. (1999) Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence. Am J Pathol 155:105-13
|
|
Simoneau, M; LaRue, H; Fradet, Y (1999) Low frequency of human papillomavirus infection in initial papillary bladder tumors. Urol Res 27:180-4
|
Showing the most recent 10 out of 21 publications
